rs2058502

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005228.5(EGFR):​c.89-32110C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.591 in 151,992 control chromosomes in the GnomAD database, including 27,715 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.59 ( 27715 hom., cov: 32)

Consequence

EGFR
NM_005228.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.479

Publications

12 publications found
Variant links:
Genes affected
EGFR (HGNC:3236): (epidermal growth factor receptor) The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]
EGFR Gene-Disease associations (from GenCC):
  • lung cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, G2P
  • non-small cell lung carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • inflammatory skin and bowel disease, neonatal, 2
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • neonatal inflammatory skin and bowel disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005228.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.879 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005228.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGFR
NM_005228.5
MANE Select
c.89-32110C>T
intron
N/ANP_005219.2
EGFR
NM_001346899.2
c.89-32110C>T
intron
N/ANP_001333828.1
EGFR
NM_001346900.2
c.-72+218C>T
intron
N/ANP_001333829.1C9JYS6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGFR
ENST00000275493.7
TSL:1 MANE Select
c.89-32110C>T
intron
N/AENSP00000275493.2P00533-1
EGFR
ENST00000455089.5
TSL:1
c.89-32110C>T
intron
N/AENSP00000415559.1Q504U8
EGFR
ENST00000344576.7
TSL:1
c.89-32110C>T
intron
N/AENSP00000345973.2P00533-3

Frequencies

GnomAD3 genomes
AF:
0.591
AC:
89818
AN:
151876
Hom.:
27703
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.736
Gnomad AMI
AF:
0.658
Gnomad AMR
AF:
0.544
Gnomad ASJ
AF:
0.515
Gnomad EAS
AF:
0.901
Gnomad SAS
AF:
0.628
Gnomad FIN
AF:
0.557
Gnomad MID
AF:
0.585
Gnomad NFE
AF:
0.497
Gnomad OTH
AF:
0.567
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.591
AC:
89871
AN:
151992
Hom.:
27715
Cov.:
32
AF XY:
0.597
AC XY:
44356
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.736
AC:
30512
AN:
41432
American (AMR)
AF:
0.543
AC:
8290
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.515
AC:
1786
AN:
3466
East Asian (EAS)
AF:
0.901
AC:
4670
AN:
5184
South Asian (SAS)
AF:
0.627
AC:
3020
AN:
4814
European-Finnish (FIN)
AF:
0.557
AC:
5877
AN:
10550
Middle Eastern (MID)
AF:
0.575
AC:
169
AN:
294
European-Non Finnish (NFE)
AF:
0.497
AC:
33765
AN:
67956
Other (OTH)
AF:
0.561
AC:
1186
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1801
3601
5402
7202
9003
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.511
Hom.:
36677
Bravo
AF:
0.595
Asia WGS
AF:
0.714
AC:
2485
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
2.3
DANN
Benign
0.15
PhyloP100
0.48
PromoterAI
0.011
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2058502;
hg19: chr7-55177869;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.